Filtros de búsqueda

Lista de obras de

Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL

artículo científico publicado en 2020

Immunogenicity and safety of a Haemophilus influenzae B (Hib)–hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants

artículo científico publicado el 27 de agosto de 2011

Safety and Immunogenicity of a Modified Process Hepatitis B Vaccine in Healthy Infants

artículo científico publicado el 1 de julio de 2011

Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population

artículo científico publicado en 2019

Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age

scientific article published on 03 January 2009

Safety and immunogenicity of a hexavalent vaccine administered at 2, 4 and 6 months of age with or without a heptavalent pneumococcal conjugate vaccine: a randomized, open-label study

artículo científico publicado en 2013

Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥ 50 years

artículo científico publicado el 1 de diciembre de 2011

Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates

artículo científico publicado el 5 de enero de 2012

Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visi

artículo científico publicado en 2014

Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of age

artículo científico publicado en 2010